Understand your diagnosis, treatments, side effects, costs and clinical-trial options — with information relevant to where you live.
Not sure where to begin? Start with one of these — or ask in your own words.
CancerAsia.AI supports your care team — it doesn't replace it.
CancerAsia.AI helps you understand the findings in your report — including cancer type, stage, biomarkers and what they may mean for treatment.
“Invasive ductal carcinoma, pT2N1M0, ER+/PR+/HER2-, Ki-67 18%, margins negative.”
This describes Stage IIA hormone-receptor-positive breast cancer. The report says the surgical margins are clear. Your doctor can explain how these findings affect treatment recommendations and outlook.
General AI gives general answers. CancerAsia.AI uses your cancer context, country and available medical information to make the answer more relevant to you.
Cancer information with your situation in mind.
CancerAsia.AI brings together your cancer context, country and available medical information to make answers more relevant to you.
Built around diagnosis, treatment, side effects, medical reports and clinical trials.
Can use the medical information and reports you choose to provide.
Considers where you live, including local treatment and clinical-trial options where available.
Designed to explain medical information clearly and show the basis for important claims.
Plain-language guides on diagnosis, treatment, side effects, caregiving and clinical trials.
CancerAsia.AI was built by people who have had cancer, and by people who have cared for someone with cancer. Our information is shaped with oncologist input, and written for people across Asia.